IM Therapeutics
PrivateLast Round
Series A
Oct 9, 2019
Total Funding Raised
$10.23M
Company Overview
IM Therapeutics is a clinical-stage biopharmaceutical company that develops personalized oral therapies for autoimmune diseases by targeting human leukocyte antigen (HLA) gene variants.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IM Therapeutics Comparables
Compare IM Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phaim Pharma | 84% | |
| Imcyse | 81% | |
| Anokion | 74% | |
IM Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 9, 2019 | ||||
| Grant | Nov 14, 2018 |
IM Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Morningside Ventures | Series A |
| JDRF | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 9, 2019
$10M round led by Morningside Ventures and JDRF.
- Nov 14, 2018
$225K grant received from Americas Seed Fund and NIH RADx.
IM Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IM Therapeutics's valuation, stock price, and market status.